Priority Date: 25.11.11 (SG 20110008800)

NATURAL-KILLER/T-CELL LYMPHOMA (NKTCL) SUSCEPTIBILITY PREDICTION, DIAGNOSIS AND THERAPY

  • Application ID: EP12799341
  • Status: PATENT GRANTED

Applicant

Attorneys

operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 171 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 25.11.2011 - Priority Date (SG 20110008800)
  • 30.05.2013 - Publication A2 (WO2013077814)
  • 01.10.2014 - Publication A2 (EP2782562)
  • 21.12.2016 - Publication B1 (EP2782562)

IPC Classification